JP2020514418A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514418A5 JP2020514418A5 JP2020500006A JP2020500006A JP2020514418A5 JP 2020514418 A5 JP2020514418 A5 JP 2020514418A5 JP 2020500006 A JP2020500006 A JP 2020500006A JP 2020500006 A JP2020500006 A JP 2020500006A JP 2020514418 A5 JP2020514418 A5 JP 2020514418A5
- Authority
- JP
- Japan
- Prior art keywords
- derivatives
- mitribocin
- alkene
- alkenes
- amides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001336 alkenes Chemical class 0.000 claims 15
- -1 cyclic alkene Chemical class 0.000 claims 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 150000001299 aldehydes Chemical class 0.000 claims 6
- 150000001408 amides Chemical class 0.000 claims 6
- 150000001412 amines Chemical class 0.000 claims 6
- 150000002148 esters Chemical class 0.000 claims 6
- 150000002170 ethers Chemical class 0.000 claims 6
- 150000002390 heteroarenes Chemical class 0.000 claims 6
- 150000002576 ketones Chemical class 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 230000002438 mitochondrial effect Effects 0.000 claims 5
- 230000008685 targeting Effects 0.000 claims 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- 150000001344 alkene derivatives Chemical class 0.000 claims 3
- 150000001361 allenes Chemical class 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 235000010233 benzoic acid Nutrition 0.000 claims 3
- 150000001558 benzoic acid derivatives Chemical class 0.000 claims 3
- 150000001559 benzoic acids Chemical class 0.000 claims 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 3
- 229910052794 bromium Inorganic materials 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 3
- 150000001735 carboxylic acids Chemical class 0.000 claims 3
- 239000000460 chlorine Substances 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 239000011737 fluorine Substances 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- 125000002950 monocyclic group Chemical class 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 3
- 150000002989 phenols Chemical class 0.000 claims 3
- 239000011593 sulfur Substances 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 230000032683 aging Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 108050006400 Cyclin Proteins 0.000 claims 1
- 102000016736 Cyclin Human genes 0.000 claims 1
- 206010011906 Death Diseases 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 102000017033 Porins Human genes 0.000 claims 1
- 108010013381 Porins Proteins 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000003712 anti-aging effect Effects 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 235000020827 calorie restriction Nutrition 0.000 claims 1
- 150000001767 cationic compounds Chemical class 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 239000002583 male contraceptive agent Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000005445 natural material Substances 0.000 claims 1
- 229940055076 parasympathomimetics choline ester Drugs 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 claims 1
- 230000002165 photosensitisation Effects 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 150000003248 quinolines Chemical class 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 230000001235 sensitizing effect Effects 0.000 claims 1
- 239000000308 sperm immobilizing agent Substances 0.000 claims 1
- 229940126585 therapeutic drug Drugs 0.000 claims 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-O triphenylphosphanium Chemical compound C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-O 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022109390A JP7312891B2 (ja) | 2017-03-15 | 2022-07-07 | ミトリボシン：癌細胞、細菌、及び病原性酵母を標的とした、ミトコンドリアベースの治療薬 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762471688P | 2017-03-15 | 2017-03-15 | |
| US62/471,688 | 2017-03-15 | ||
| PCT/US2018/022403 WO2018170109A1 (en) | 2017-03-15 | 2018-03-14 | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022109390A Division JP7312891B2 (ja) | 2017-03-15 | 2022-07-07 | ミトリボシン：癌細胞、細菌、及び病原性酵母を標的とした、ミトコンドリアベースの治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020514418A JP2020514418A (ja) | 2020-05-21 |
| JP2020514418A5 true JP2020514418A5 (enExample) | 2021-04-15 |
| JP7104134B2 JP7104134B2 (ja) | 2022-07-20 |
Family
ID=63523316
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020500006A Active JP7104134B2 (ja) | 2017-03-15 | 2018-03-14 | ミトリボシン：癌細胞、細菌、及び病原性酵母を標的とした、ミトコンドリアベースの治療薬 |
| JP2022109390A Active JP7312891B2 (ja) | 2017-03-15 | 2022-07-07 | ミトリボシン：癌細胞、細菌、及び病原性酵母を標的とした、ミトコンドリアベースの治療薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022109390A Active JP7312891B2 (ja) | 2017-03-15 | 2022-07-07 | ミトリボシン：癌細胞、細菌、及び病原性酵母を標的とした、ミトコンドリアベースの治療薬 |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US11311501B2 (enExample) |
| EP (1) | EP3596043B1 (enExample) |
| JP (2) | JP7104134B2 (enExample) |
| KR (1) | KR102623283B1 (enExample) |
| CN (1) | CN110621655B (enExample) |
| AU (2) | AU2018235937A1 (enExample) |
| BR (1) | BR112019019109B1 (enExample) |
| CA (1) | CA3056086A1 (enExample) |
| CL (1) | CL2019002580A1 (enExample) |
| CO (1) | CO2019010027A2 (enExample) |
| CR (2) | CR20220381A (enExample) |
| CU (3) | CU20190096A7 (enExample) |
| DO (3) | DOP2019000230A (enExample) |
| EC (1) | ECSP19073204A (enExample) |
| IL (2) | IL305316B2 (enExample) |
| MX (3) | MX2022000938A (enExample) |
| NZ (1) | NZ756854A (enExample) |
| PE (1) | PE20191485A1 (enExample) |
| PH (1) | PH12019502056B1 (enExample) |
| RU (1) | RU2019132396A (enExample) |
| SG (1) | SG11201908487YA (enExample) |
| WO (1) | WO2018170109A1 (enExample) |
| ZA (5) | ZA201905970B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2744989B2 (ja) | 1992-07-24 | 1998-04-28 | 光洋機械工業株式会社 | 小径工作物の外径寸法測定システム |
| US20220339125A1 (en) * | 2017-03-15 | 2022-10-27 | Lunella Biotech, Inc. | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast |
| CA3078791A1 (en) | 2017-10-11 | 2019-04-18 | Lunella Biotech, Inc. | Anti-mitochondrial inhibitors for oncogenic ras and myc |
| EP3810284A4 (en) | 2018-06-01 | 2022-06-15 | Lunella Biotech, Inc. | BIOMARKERS AND THERAPEUTICS IN RESISTANCE TO ENDOCRINE THERAPY |
| CA3114888A1 (en) | 2018-10-02 | 2020-04-09 | Lunella Biotech, Inc. | Azithromycin and roxithromycin derivatives as senolytic drugs |
| KR20210104830A (ko) * | 2018-12-17 | 2021-08-25 | 루넬라 바이오테크 인코포레이티드 | 항노화를 위한 삼중 조합 요법 |
| KR20210104829A (ko) * | 2018-12-17 | 2021-08-25 | 루넬라 바이오테크 인코포레이티드 | 미토콘드리아를 표적화하고 암 줄기 세포를 사멸시키는 삼중 조합 요법 |
| CN114025769A (zh) * | 2019-04-16 | 2022-02-08 | 卢内拉生物技术有限公司 | 用于靶向线粒体和抗癌治疗的烷基-tpp化合物 |
| EP3976197B1 (en) * | 2019-05-24 | 2025-07-16 | Lunella Biotech, Inc. | Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer |
| CA3180522A1 (en) | 2020-04-24 | 2021-10-28 | Lunella Biotech, Inc. | Therapeutic methods for preventing tumor metastasis and tumor recurrence |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2062025A (en) * | 1931-12-19 | 1936-11-24 | Harrington Joseph | Method and apparatus for treating moisture-containing substances |
| US2059764A (en) * | 1933-11-03 | 1936-11-03 | Zerillo Frank | Pneumatic tire |
| US2058655A (en) * | 1934-10-12 | 1936-10-27 | Borg Warner | Friction clutch |
| JPS537424B2 (enExample) * | 1971-10-08 | 1978-03-17 | ||
| US5756507A (en) | 1995-12-14 | 1998-05-26 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| JP2000001433A (ja) | 1998-06-11 | 2000-01-07 | Pfizer Pharmaceuticals Inc | ５―リポキシゲナ―ゼ阻害剤 |
| GB0323585D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
| WO2005089269A2 (en) * | 2004-03-16 | 2005-09-29 | Temple University - Of The Commonwealth System Of Higher Education | Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| US8778874B2 (en) * | 2004-11-29 | 2014-07-15 | National University Corporation Nagoya University | Glycopeptide antibiotic monomer derivatives |
| CN101495113A (zh) * | 2006-04-21 | 2009-07-29 | 史密丝克莱恩比彻姆公司 | Il-8受体拮抗剂 |
| CN101730692A (zh) | 2007-03-15 | 2010-06-09 | 先灵公司 | 用作葡聚糖合成酶抑制剂的哒嗪酮衍生物 |
| FR2932483A1 (fr) * | 2008-06-13 | 2009-12-18 | Cytomics Systems | Composes utiles pour le traitement des cancers. |
| JP6068803B2 (ja) * | 2009-01-29 | 2017-01-25 | コー，ヤング，ヒー | 癌治療用組成物及び癌治療方法 |
| KR20120100706A (ko) * | 2009-05-20 | 2012-09-12 | 유니베르시떼 드 제네브 | 암 개시세포의 미토콘드리아 활성 저해제 및 이의 용도 |
| CA2806341C (en) * | 2010-07-29 | 2020-03-24 | Rigel Pharmaceuticals, Inc. | Ampk-activating heterocyclic compounds and methods for using the same |
| US20140288077A1 (en) * | 2011-07-05 | 2014-09-25 | St. Jude Children's Research Hospital | Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity |
| CN102886054B (zh) * | 2011-07-19 | 2014-04-02 | 复旦大学 | 一种抑制细菌信号转导系统PhoQ组氨酸激酶活性的制剂 |
| DK2950649T3 (da) * | 2013-02-01 | 2020-05-04 | Wellstat Therapeutics Corp | Aminforbindelser med antiinflammations-, antisvampe-, antiparasit- og anticanceraktivitet |
| CA2884607A1 (en) | 2015-03-11 | 2016-09-11 | Stealth Peptides International, Inc. | Therapeutic compositions including acrylamido compounds or phenyl-substiituted maleimide compounds and uses thereof to treat and prevent mitochondrial diseases and conditions |
-
2018
- 2018-03-14 CU CU2019000096A patent/CU20190096A7/es unknown
- 2018-03-14 CR CR20220381A patent/CR20220381A/es unknown
- 2018-03-14 EP EP18767458.5A patent/EP3596043B1/en active Active
- 2018-03-14 CR CR20190458A patent/CR20190458A/es unknown
- 2018-03-14 IL IL305316A patent/IL305316B2/en unknown
- 2018-03-14 IL IL269309A patent/IL269309B2/en unknown
- 2018-03-14 WO PCT/US2018/022403 patent/WO2018170109A1/en not_active Ceased
- 2018-03-14 PE PE2019001841A patent/PE20191485A1/es unknown
- 2018-03-14 US US16/493,871 patent/US11311501B2/en active Active
- 2018-03-14 CN CN201880031954.5A patent/CN110621655B/zh active Active
- 2018-03-14 BR BR112019019109-7A patent/BR112019019109B1/pt active IP Right Grant
- 2018-03-14 SG SG11201908487Y patent/SG11201908487YA/en unknown
- 2018-03-14 CU CU2019000079A patent/CU20190079A7/es unknown
- 2018-03-14 MX MX2022000938A patent/MX2022000938A/es unknown
- 2018-03-14 MX MX2019010759A patent/MX390968B/es unknown
- 2018-03-14 RU RU2019132396A patent/RU2019132396A/ru unknown
- 2018-03-14 PH PH1/2019/502056A patent/PH12019502056B1/en unknown
- 2018-03-14 CA CA3056086A patent/CA3056086A1/en active Pending
- 2018-03-14 NZ NZ756854A patent/NZ756854A/en unknown
- 2018-03-14 MX MX2022000937A patent/MX2022000937A/es unknown
- 2018-03-14 CU CU2019000097A patent/CU20190097A7/es unknown
- 2018-03-14 KR KR1020197029542A patent/KR102623283B1/ko active Active
- 2018-03-14 JP JP2020500006A patent/JP7104134B2/ja active Active
- 2018-03-14 AU AU2018235937A patent/AU2018235937A1/en not_active Abandoned
- 2018-11-29 US US16/204,173 patent/US10512618B2/en active Active
-
2019
- 2019-09-06 DO DO2019000230A patent/DOP2019000230A/es unknown
- 2019-09-10 CL CL2019002580A patent/CL2019002580A1/es unknown
- 2019-09-10 ZA ZA2019/05970A patent/ZA201905970B/en unknown
- 2019-09-16 CO CONC2019/0010027A patent/CO2019010027A2/es unknown
- 2019-10-10 EC ECSENADI201973204A patent/ECSP19073204A/es unknown
- 2019-10-31 US US16/670,443 patent/US11364210B2/en active Active
- 2019-10-31 US US16/670,326 patent/US11547679B2/en active Active
-
2020
- 2020-02-19 ZA ZA2020/01040A patent/ZA202001040B/en unknown
- 2020-02-19 ZA ZA2020/01041A patent/ZA202001041B/en unknown
-
2021
- 2021-03-05 ZA ZA2021/01517A patent/ZA202101517B/en unknown
-
2022
- 2022-03-29 ZA ZA2022/03603A patent/ZA202203603B/en unknown
- 2022-07-07 JP JP2022109390A patent/JP7312891B2/ja active Active
- 2022-07-13 AU AU2022205218A patent/AU2022205218B2/en active Active
- 2022-08-11 DO DO2022000164A patent/DOP2022000164A/es unknown
- 2022-08-11 DO DO2022000165A patent/DOP2022000165A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020514418A5 (enExample) | ||
| CN114126629B (zh) | 用于生成一氧化氮的方法和组合物及其用于经由呼吸道输送一氧化氮的用途 | |
| CN114206325B (zh) | 用于生成一氧化氮的方法和组合物及其用途 | |
| JP5380078B2 (ja) | アレナウイルス感染の治療のための抗ウイルス薬剤 | |
| US20240131046A1 (en) | Anti-viral agent | |
| JP5524858B2 (ja) | 抗菌性化合物 | |
| RU2019132396A (ru) | Миторибосцины: терапевтические средства на основе митохондрий, направленные на раковые клетки, бактерии и патогенные дрожжи | |
| CN115768413B (zh) | 用于治疗及抗击结核病的方法和组合物 | |
| JP2023526584A (ja) | Ｓａｒｓ－ｃｏｖ及びｓａｒｓ－ｃｏｖ－２の治療に使用するための一酸化窒素または一酸化窒素放出組成物 | |
| US20200054595A1 (en) | EGCG-Palmitate Compositions and Methods of Use Thereof | |
| US20160106689A1 (en) | Use | |
| CN106687140A (zh) | 半胱胺在治疗由酵母菌/霉菌引起的感染中的用途 | |
| EP3934653B1 (en) | Azelastine as antiviral treatment | |
| JPH09249560A (ja) | 抗ウイルス剤と抗菌剤 | |
| JP2011522039A (ja) | ウイルス抑制剤として有用なジアリールヘパトノイド系化合物 | |
| CN101500984A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 | |
| GB2475359A (en) | A compound for use in treating a fulminant respiratory disorder | |
| WO2024230460A1 (zh) | 五环三萜结构修饰化合物在制备白癜风药物中的应用及新制剂 | |
| JP2015524460A5 (enExample) | ||
| CN112716954B (zh) | 氯化两面针碱的药物新用途 | |
| US20230285441A1 (en) | Treatment of coronavirus infections with auranofin | |
| US20110150767A1 (en) | Alpha-substituted and alpha-unsubstituted aromatic amino acid derivatives and compositions thereof for use to treat, diagnose, or monitor a medical condition | |
| EP3976018B1 (en) | Composition for use in the treatment of foot and mouth disease (fmd), scabby mouth (orf), picornavirus, parapoxvirus, and a pathogenic disease causing pox lesions | |
| WO2023137962A1 (zh) | 一种氧化异阿朴菲生物碱衍生物及其制备方法和抗抑郁用途 | |
| KR20230015320A (ko) | 감염성 질환의 치료에서의 부실라민의 용도 |